Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
A-1-Antichymotrypsin | RMab | EP384 | IgG | Tonsil, Lymph Node, Thymus, Spleen, Liver, Colon | Human | Cytoplasmic | 1:50-1:200 |
A-1-Antichymotrypsin | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Thymus, Breast | Human | Cytoplasmic | 1:250-1:1000 |
A-1-Antitrypsin | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Spleen, Pancreas, Myometrium | Human, Baboon, Equine, Mink | Cytoplasmic | 1:250-1:1000 |
ACTH | MMab | BSB-25 | IgG1/K | Normal Pituitary | Human | Cytoplasmic | 1:250-1:1000 |
Actin Muscle Specific | MMab | HHF35 | IgG1/K | Skeletal Muscle, Appendix, Prostate | Human | Cytoplasmic | 1:50-1:200 |
Actin Smooth Muscle | MMab | BSB-15 (ASM/H12) | IgG2a/K | Appendix, Uterus | Human, Mouse, Rabbit, Dog, Cat, Rat, Sheep, Pig | Cytoplasmic | 1:250-1:1000 |
ACE2 | MMab | BSB-135 | IgG1 | Kidney, Testis, Brain, Colon, Fallopian Tube | Human | Membranous, Cytoplasmic | 1:25-1:100 |
Adenovirus | MMab | 20/11 and 2/6 | IgG1/K | Adenovirus Infected Tissue | Human | Cytoplasmic, Nuclear | 1:25-1:100 |
Adipophilin/ADRP | MMab | BSB-91 | IgG1 | Adrenal, SCC, TCC and Sebaceous Neoplasms | Human | Membranous, Cytoplasmic | 1:50-1:200 |
Albumin | RPab | polyclonal | IgG | Salivary Gland, Kidney, Tonsil, Lupus Erythematosus | Human | Cytoplasmic | 1:50-1:200 |
ALDH1A1 | RMab | EP168 | IgG | Kidney, Liver, Testis, Colon Cancer, Breast Cancer | Human | Cytoplasmic | 1:100-1:500 |
ALK-1/CD246 | RMab | EP302 | IgG | Anaplastic Large Cell Lymphoma | Human, Predicted: Mouse, Rat | Cytoplasmic, Nuclear | 1:50-1:200 |
ALK-1/CD246 | RMab | RBT-ALK1 | IgG | Anaplastic Large Cell Lymphoma | Human | Cytoplasmic, Nuclear | 1:100-1:500 |
Alpha Synuclein | MMab | BSB-114 | IgG2a/K | Brain, Breast, Skin, Tonsil, Bone Marrow, Alzheimer’s Disease, Parkinson’s Disease | Human | Cytoplasmic, Nuclear | 1:25-1:100 |
Alpha-Fetoprotein | RMab | EP209 | IgG | Fetal Liver, Liver Lesions, Hepatocellular Carcinoma | Human | Cytoplasmic | 1:50-1:200 |
Alpha-Fetoprotein | MMab | BSB-23 | IgG2a/K | Fetal Liver, Liver Lesions, Hepatocellular Carcinoma | Human | Cytoplasmic | 1:100-1:500 |
AMACRacemase/P504S | RMab | 13H4 | IgG | Kidney, Liver, Salivary Gland, Prostate Lesions, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:25-1:100 |
Amyloid A | RMab | EP335 | IgG | Kidney, Amyloidosis | Human | Extracelular, Cytoplasmic | 1:50-1:200 |
Amyloid Beta | RMab | RBT-A4 | IgG | Testis, Kidney, Pancreas, Salivary Galnd, Alzheimer’s Disease | Human, Mouse, Rat | Cytoplasmic, Nuclear | 1:50-1:200 |
Androgen Receptor | MMab | BSB-4 (AR-D12) | IgG1 | Prostate, Testis, Breast, Cervix, Fallopian Tube, Prostatic Adenocarcinoma | Human | Nuclear | 1:100-1:500 |
Annexin A1 | MMab | BSB-95 | IgG2b | Liver, Tonsil, Spleen, Thymus, Lung, Colon, Hairy Cell Leukemia | Human, Rat | Cytoplasmic, Membranous | 1:100-1:500 |
Arginase-1 | RMab | EP261 | IgG | Liver, Hepatocellular Carcinoma | Human | Cytoplasmic, Nuclear | 1:50-1:200 |
ATRX | MMab | BSB-108 | IgG2a/K | Breast, Tonsil, Testis, Salivary Gland, Placenta, TCC, Astrocytoma | Human, Mouse, Rat | Nuclear | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
B7H3/CD276 | RMab | RBT-B7H3 | IgG | Testis, Adrenal, Tonsil, Breast, Fallopian Tube, Breast Carcinoma, Prostate Carcinoma and Ovarian Carcinoma | Human, Predicted: Mouse | Membranous | 1:25-1:100 |
BAP1 | MMab | BSB-109 | IgG1 | Testis, TCC, Mesothelioma | Human, Mouse, Rat | Nuclear | 1:50-1:200 |
Bax | RMab | E63 | IgG | Breast, Tonsil, Cervix, Hodgkin’s Lymphoma | Human | Cytoplasmic , Cell Membranous | 1:50-1:200 |
BCA-225 | MMab | Cu-18 | IgG1/K | Breast, Lung, Uterus, Cervical Carcinoma | Human | Cytoplasmic | 1:25-1:100 |
bcl-10 | MMab | BSB-22 | IgG1/K | Tonsil, Spleen, Thymus, MALT Lymphomas | Human | Cytoplasmic, Nuclear | 1:100-1:500 |
bcl-2 | MMab | BSB-5 (BCL2/A4) | IgG1/K | Tonsil, Lymph Node, Breast, Bone Marrow, Fallopian Tube | Human | Cytoplasmic, Membranous | 1:50-1:200 |
bcl-2 | RMab | EP36 | IgG | Tonsil, Lymph Node, Breast, Placenta, Fallopian Tube | Human, Predicted: Mouse | Cytoplasmic, Membranous | 1:50-1:200 |
bcl-6 | RMab | RBT-bcl6 | IgG | Tonsil, Lymph Node, Thymus, Skin, Breast, Brain, Follicular Lymphoma | Human | Nuclear | 1:50-1:200 |
bcl-6 | RMab | EP278 | IgG | Tonsil, Follicular Lymphoma | Human, Predicted: Mouse, Rat | Nuclear | 1:25-1:100 |
bcl-6 | MMab | BSB-26 | IgG1 | Tonsil, Lymph Node, Thymus, Skin, Breast, Brain, Follicular Lymphoma | Human | Nuclear | 1:50-1:200 |
Bcl-x | RMab | EP94 | IgG | Kidney, Tonsil, Cervix, Hodgkin’s Lymphoma | Human, Predicted: Mouse, Rat | Cytoplasmic, Membranous | 1:250-1:1000 |
BCOR | MMab | BSB-128 | IgG1/K | Testis, Cervix, Prostate, TCC, Angiosarcoma | Human | Nuclear | 1:10-1:25 |
Beta-Catenin | RMab | EP35 | IgG | Fibromatosis – Breast Ca/Abdomen | Human, Predicted: Mouse, Rat, Sheep, Hamster, Cow, Macaque Monkey, African Green Monkey | Cytoplasmic, Membranous, Nuclear | 1:25-1:100 |
Beta-Catenin | MMab | 14 | IgG1 | Fibromatosis – Breast Ca/Abdomen | Human, Dog, Mouse, Rat, Chicken | Cytoplasmic, Membranous, Nuclear | 1:50-1:200 |
BG8 LewisY | MMab | F3 | IgM | Placenta, Tonsil, Pancreas, Cervix, Bladder TCC, Lung Adenocarcinoma | Human | Cytoplasmic | 1:10-1:50 |
BOB.1 | RMab | EP114 | IgG | Tonsil, Lymph Node | Human | Cytoplasmic, Nuclear | 1:100-1:500 |
Brachyury | RMab | RBT-TBXT | IgG | Pituitary, Brain, Chordoma | Human | Cytoplasmic | 1:25-1:100 |
BRAF V600E | RMab | RM8 | IgG | Human | Cytoplasmic | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
C1q | RPab | Polyclonal | IgG | Kidney, Cervix, Spleen, Lupus Erythematosus | Human | Cytoplasmic | 1:25-1:100 |
C3c | RPab | Polyclonal | IgG | Placenta, Kidney, Fallopian Tube, Lupus Erythematosus | Human | Cytoplasmic | 1:50-1:200 |
C3d | RPab | Polyclonal | IgG | Kidney Transplant Rejection | Human | Cytoplasmic, Membranous | 1:50-1:200 |
C4c | RPab | Polyclonal | IgG | Teestis, Kidney, Pancreas, Salivary Gland, Colon | Human | Cytoplasmic | 1:50-1:200 |
C4d | RMab | EP272 | IgG | Tonsil, Lymph Node, Spleen, Kidney, Kidney Transplant Rejection | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CA-125 | MMab | OC125 | IgG1/K | Colon, Pancreas, Epithelioid Mesothelioma, Ovarian Carcinoma | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CA-125 | RMab | EP48 | IgG | Colon, Pancreas, Epithelioid Mesothelioma, Ovarian Carcinoma, | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CA15-3 | MMab | DF3 | IgG1/K | Kidney, Breast, Lymph Node, Cervix, Salivary Gland, Bladder TCC | Human | Cytoplasmic, Membranous | 1:250-1:1000 |
CA19-9 | MMab | 121SLE | IgM | Colon, Cervix, Pancreas, Pancreas Cancer, Breast, Breast Carcinoma, Colon Carcinoma, Transitional Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma | Human | Cytoplasmic | 1:100-1:500 |
Cadherin17/LI-Cadherin | RMab | EP86 | IgG | Colon Carcinoma | Human | Cytoplasmic | 1:25-1:100 |
Cadherin-6 | RMab | EP217 | IgG | Kidney, Renal Cell Carcinoma | Human, Predicted: Mouse, Rat | Membranous | 1:25-1:100 |
Calcitonin | RMab | EP92 | IgG | Thyroid Carcinoma, Medullary Carcinoma of Thyroid | Human | Cytoplasmic | 1:100-1:500 |
Calcitonin | RPab | Polyclonal | IgG | Thyroid Carcinoma, Medullary Carcinoma of Thyroid | Human, Dog, Cat | Cytoplasmic | 1:100-1:500 |
Caldesmon | MMab | BSB-19 (CALD-31) | IgG1/K | Appendix, Uterus, Breast Ducts, Leiomyoma, Colon, Prostate, Skin, Kidney, Myometrium | Human | Cytoplasmic | 1:100-1:400 |
Calponin | MMab | BSB-20 (CALP-A6) | IgG1/K | Appendix, Uterus, Breast Ducts, Leiomyoma, Prostate, Colon, Breast, Skin | Human, Canine, Feline | Cytoplasmic | 1:50-1:200 |
Calretinin | RMab | EP1798 | IgG | Brain, Testis, Colon, Benign Mesothelial Cells, Malignant Mesothelioma | Human, Mouse, Rat | Cytoplasmic, Nuclear | 1:100-1:500 |
Carbonic Anhydrase 9 | RMab | EP161 | IgG | Stomach, Gallbladder, Kidney Carcinoma, Cervix Carcinoma, Lung Carcinoma | Human | Cytoplasmic, Membranous | 1:25-1:100 |
Caveolin-1 | RMab | EP353 | IgG | Placenta, Liver, Kidney, Spleen, Lung, Mesothelioma, Ewing’s Sarcoma, RCC | Human | Membranous | 1:50-1:200 |
CD10 | MMab | 56C6 | IgG1 | Kidney, Tonsil, Lymph Node, Liver, Breast, Prostate, Lung, Pancreas, Salivary Gland, Thymus | Human, Dog, Cat | Cytoplasmic, Membranous | 1:10-1:50 |
CD10 | RMab | EP195 | IgG | Kidney, Tonsil, Lymph Node, Liver, Breast, Prostate, Lung, Pancreas, Salivary Gland, Thymus | Human, Predicted: Rat | Cytoplasmic, Membranous | 1:10-1:50 |
CD103/ITGAE | RMab | EP206 | IgG | Skin, Colon, Tonsil, Thymus, Spleen, Hairy Cell Leukemia | Human | Cytoplasmic, Membranous | 1:25-1:100 |
CD105 | RMab | EP274 | IgG | Spleen, Tonsil, Cervix, Lymphoblastic Lymphoma | Human | Cytoplasmic | 1:50-1:200 |
CD105/Endoglin | RPab | Polyclonal | IgG | Spleen, Tonsil, Cervix, Lymphoblastic Lymphoma | Human, Mouse | Cytoplasmic | 1:25-1:100 |
CD117 | RMab | EP10 | IgG | Skin, Testis, Breast, GIST, Colon, Brain, Tonsil | Human, Monkey, Predicted: Marmoset | Cytoplasmic, Membranous | 1:100-1:500 |
CD11b | RMab | EP45 | IgG | Spleen, Leukemia | Human, Predicted: Mouse | Cytoplasmic | 1:100-1:400 |
CD11c | RMab | EP157 | IgG | Bone Marrow, Spleen, Tonsil, Colon, Liver, Hairy Cell Leukemia | Human | Cytoplasmic | 1:25-1:50 |
CD123 IL-3Ra | MMab | BSB-59 (CD123-D3) | IgG1/K | Tonsil, Lymph Node, Kikuchi-Fujimoto Disease | Human | Cytoplasmic, Membranous | 1:25-1:100 |
CD13 | MMab | 38C12 | IgG1 | Spleen, Tonsil, Prostate, Liver | Human | Cytoplasmic, Membranous | 1:25-1:50 |
CD13 | RMab | EP117 | IgG | Spleen, Tonsil, Prostate, Liver | Human, Predicted: Rat | Cytoplasmic, Membranous | 1:50-1:200 |
CD138 | RMab | EP201 | IgG | Tonsil, Liver, Kidney, Breast, Lymph Node, Cervix, Plasmacytoma, Adrenal, Skin, Colon, Lung | Human, Predicted: Mouse, Rat | Membranous | 1:25-1:100 |
CD138 | MMab | B-A38 | IgG1 | Tonsil, Liver, Kidney, Breast, Lymph Node, Cervix, Plasmacytoma | Human | Membranous | 1:50-1:200 |
CD14 | RMab | EP128 | IgG | Placenta, Tonsil, Spleen, Diffuse Large B-cell Lymphoma | Human | Cytoplasmic, Membranous | 1:25-1:100 |
CD14 | MMab | 7 | Ig2a | Placenta, Tonsil, Spleen, Diffuse Large B-cell Lymphoma | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CD146/MUC18/Mel-CAM | MMab | BSB-122 | IgG1/K | Human | Cytoplasmic | 1:25-1:100 | |
CD15 | RMab | EP273 | IgG | Tonsil, Lymph Node, Hodgkin’s Lymphoma | Human | Cytoplasmic, Membranous | 1:25-1:100 |
CD15 | MMab | BSB-119 | IgM | Tonsil, Lymph Node, Hodgkin’s Lymphoma | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CD16 | RMab | EP364 | IgG | Placenta, Liver, Breast, Spleen, Thymus, Lung | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CD163 | MMab | 10D6 | IgG1 | Placenta, Tonsil, Lymph Node, Inflamed Tissue, H Hylori Infected Tissues | Human | Cytoplasmatic, Membranous | 1:25-1:100 |
CD163 | RMab | EP324 | IgG | Placenta, Tonsil, Lymph Node, Inflamed Tissue, H Hylori Infected Tissues | Human | Cytoplasmatic, Membranous | 1:50-1:200 |
CD19 | MMab | BSB-97 | IgG1 | Tonsil, Lymph Node, Spleen, Colon | Human | Membranous | 1:25-1:100 |
CD19 | RMab | EP169 | IgG | Tonsil, Lymph Node | Human | Membranous | 1:25-1:100 |
CD1a | RMab | EP80 | IgG | Skin, Thymus, Lymphoblastic Lymphoma | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CD2 | MMab | AB75 | IgG1/K | Tonsil, Lymph Node, Colon, Fallopian Tube, Thymus, Spleen | Human | Membranous | 1:25-1:100 |
CD20 | MMab | L26 | IgG2a/K | Tonsil, Lymph Node | Human, Canine, Feline | Membranous | 1:250-1:1000 |
CD21 | RMab | EP64 | IgG | Tonsil, Lymph Node, Spleen | Human, Predicted: Mouse | Membranous | 1:50-1:200 |
CD23 | RMab | EP75 | IgG | Tonsil, Lymph Node | Human | Membranous | 1:50-1:200 |
CD23 | MMab | 1B12 | IgG | Tonsil, Lymph Node | Human | Membranous | 1:25-1:100 |
CD25 | MMab | 4C9 | IgG2b | Tonsil, Small Bowel, Colon, Spleen, Mastocytosis, Hodgkin’s Lymphoma | Human, Mouse | Cytoplasmic, Membranous | 1:10-1:50 |
CD25 | RMab | RBT-CD25 | IgG | Tonsil, Small Bowel, Colon, Spleen, Mastocytosis, Hodgkin’s Lymphoma | Human | Cytoplasmic, Membranous | 1:10-1:50 |
CD3 | RMab | RBT-CD3 | IgG | Tonsil, Lymph Node, Liver, Testis, Kidney, Colon, Spleen, Thymus, Lymphoblastic Lymphoma | Human | Membranous | 1:50-1:200 |
CD3 Epsilon | RMab | RBT-CD3e | IgG | Tonsil, Lymph Node | Human | Membranous | 1:100-1:500 |
CD30 | MMab | Ber-H2 | IgG1/K | Tonsil, Lymph Node, Hodgkin’s Lymphoma | Human | Membranous | 1:100-1:500 |
CD31 | MMab | 1A10 | IgG1/K | Tonsil, Placenta, Appendix, Spleen, Kidney | Human, Dog, Cat, Mouse | Cytoplasmic, Membranous | 1:50-1:200 |
CD33 | RMab | RBT-CD33 | IgG | Placenta, Myometrium, Lung, Colon, Spleen, Lymph Node, Tonsil, Acute Myeloid Leukemia | Human | Membranous | 1:10-1:50 |
CD34 | MMab | QBEnd/10 | IgG1 | Tonsil, Placenta, Appendix | Human | Cytoplasmic, Membranous | 1:100-1:500 |
CD34 | RMab | EP88 | IgG | Tonsil, Placenta, Appendix | Human, Predicted: Mouse, Rat, Sheep, Dog, Pig, Loxodonta Africana | Cytoplasmic, Membranous | 1:50-1:200 |
CD35 | RMab | EP197 | IgG | Tonsil, Lymph Node | Human | Membranous | 1:50-1:200 |
CD35 | MMab | RLB25 | IgG2b | Tonsil, Lymph Node | Human | Membranous | 1:25-1:100 |
CD38 | MMab | SPC32 | IgG1 | Tonsil, Lymph Node, Spleen, Prostate, Salivary Gland | Human, Rabbit | Membranous | 1:25-1:100 |
CD38 | RMab | EP135 | IgG | Synthetic peptide corresponding to residues of human CD38 protein | Human | Membranous | 1:25-1:100 |
CD4 | RMab | RBT-CD4 | IgG | Tonsil, Lymph Node | Human | Membranous | 1:25-1:100 |
CD41/ Integrin alpha IIb | RMab | EP178 | IgG | Spleen, Bone Marrow | Human | Cytoplasmic, Membranous | 1:25-1:100 |
CD42b | RMab | EP409 | IgG | Bone Marrow, Spleen | Human | Cytoplasmic | 1:25-1:100 |
CD43 | MMab | MT1 | IgG1 | Human lymph node cells | Human | Membranous | 1:100-1:500 |
CD44 | MMab | BSB-12 | IgG2a | Urothelium, Tonsil, Kidney, Breast, Liver, Skin, Prostate, Thymus, Spleen, Lymph Node, Esophageal Carcinoma | Human | Membranous | 1:250-1:1000 |
CD45 | MMab | 2B11 & PD7/26 | IgG1/K | Tonsil, Lymph Node, Thymus, Spleen | Human | Membranous | 1:250-1:1000 |
CD45R | MMab | MB1 | IgG1 | Tonsil, Lymph Node | Human | Membranous | 1:25-1:100 |
CD45RA | MMab | 4KB5 | IgG1/K | Tonsil, Lymph Node | Human | Membranous | 1:25-1:100 |
CD45RO | MMab | UCHL-1 | IgG2a/K | Tonsil, Lymph Node | Human, Mouse, Rat, Non-human Primate | Membranous | 1:250-1:1000 |
CD5 | RMab | RBT-CD5 | IgG | Tonsil, Lymph Node, Spleen, Thymus | Human | Membranous | 1:25-1:100 |
CD5 | RMab | RED1 | IgG | Tonsil, Lymph Node, Spleen, Thymus | Human | Membranous | 1:50-1:200 |
CD56 | MMab | 123C3.D5 | IgG1/K | Pancreas, Neuroblastoma, Brain, Thyroid, Prostate, Colon, Lung SCC | Human | Membranous | 1:250-1:1000 |
CD57 | MMab | BSB-10 (CD57/B8) | IgG1/K | Tonsil, Lymph Node, Spleen, Prostate, Breast, Brain | Human, Dog, Cat | Membranous | 1:100-1:500 |
CD6 | MMab | BSB-54 | IgG1 | Tonsil, Lymph Node, Prostate, Colon, Spleen, Bone Marrow | Human | Cytoplasmic | 1:250-1:1000 |
CD61 | RMab | EP65 | IgG | Brain, Kidney, Testis, Bone Marrow | Human | Cytoplasmic | 1:100-1:500 |
CD61 | MMab | 2f2 | IgG1/K | Bone Marrow | Human | Cytoplasmic | 1:100-1:500 |
CD63 | MMab | NKI/C3 | IgG1/K | Skin, Malignant Melanoma | Human | Cytoplasmic, Membranous | 1:250-1:1000 |
CD68 | MMab | BSB-8 (CD68/G2) | IgG1 | Tonsil, Lymph Node | Human, Mouse, Rabbit, Rat | Cytoplasmic, Membranous | 1:250-1:1000 |
CD68 | MMab | KP-1 | IgG1/K | Tonsil, Lymph Node | Human, Hamster, Mouse, Non-Human Primate , Porcine, Rabbit, Rat, Cat, Monkey | Cytoplasmic, Membranous | 1:250-1:1000 |
CD7 | MMab | LP15 | IgG2b | Tonsil, Lymph Node, Colon, Liver, Spleen, Bone Marrow | Human | Membranous | 1:50-1:200 |
CD7 | RMab | EP132 | IgG | Tonsil, Lymph Node, Colon, Liver, Spleen, Bone Marrow, Lymphoblastic Lymphoma | Human | Membranous | 1:50-1:200 |
CD71 | MMab | 10F11 | IgGb2 | Bone Marrow, Placenta, Adrenal, Tonsil, Skin | Human | Cytoplasmic, Membranous | 1:25-1:100 |
CD74 | MMab | LN2 | IgG1 | Tonsil, Lymph Node | Human | Cytoplasmic, Membranous | 1:250-1:1000 |
CD75 | MMab | LN-1 | IgG1/k | Liver, Prostate, Kidney, Tonsil | Human | Cytoplasmic, Membranous | 1:250-1:1000 |
CD79a | MMab | JCB117 | IgG1/K | Recombinant protein containing part of the extracellular portion of the CD79a glycoprotein | Human | Membranous | 1:250-1:1000 |
CD8 | RMab | EP334 | IgG | Tonsil, Lymph Node, Liver, Colon | Human | Membranous | 1:50-1:200 |
CD8 | MMab | C8/144B | IgG/K | Tonsil, Lymph Node, Liver, Fallopian Tube, Breast, Colon, Prostate | Human | Membranous | 1:250-1:1000 |
CD99 | MMab | BSB-9 (CD99/B5) | IgG1/K | Pancreas, Thymus, Ependyma, Ewing’s Sarcoma & Soft Tissue | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CD147 | MMab | BSB-137 | IgG1 | Testis, Colon, Kidney, Stomach, Brain | Human | Cytoplasmic, Membranous | 1:50-1:200 |
CDK2 | RMab | RBT-CDK2 | IgG | Testis, Tonsil, Prostate, Placenta, Skin, Colon, Transitional Cell Carcinoma, Lymphoblastic Lymphoma | Human | Nuclear | 1:25-1:100 |
CDK4 | RMab | EP180 | IgG | Cervical and Colon Cancer | Human | Nuclear | 1:25-1:100 |
CDX2 | RMab | EP25 | IgG | Colon, Colon Adenocarcinoma | Human, Predicted: Rabbit | Nuclear | 1:50-1:200 |
CEA | MMab | BSB-13 (CEA31) | IgG1/K | Colon, Colon Adenocarcinoma | Human | Cytoplasmic | 1:250-1:1000 |
CEA | RPab | Polyclonal | IgG | Colon, Tonsil, Fallopian Tube, Colon Adenocarcinoma | Human, Dog, Cat | Cytoplasmic | 1:100-1:500 |
Chromogranin A | MMab | LK2H10 | IgG1/K | Pancreas, Pituitary, Colon, Brain | Human, Dog, Cat, Rat, Rabbit, Porcine | Cytoplasmic | 1:250-1:1000 |
Claudin-1 | RPab | Polyclonal | IgG | Skin, Small Intestine, Colon Carcinoma | Human | Membranous | 1:50-1:200 |
Claudin-5 | RMab | EP224 | IgG | Liver, Vascular Tissue, Placenta, Colon, Kidney, Fallopian Tube | Human | Cytoplasmic, Membranous | 1:25-1:100 |
Clusterin/Apolipoprotein J | RMab | EP181 | IgG | Tonsil, Lymph Node, Placenta, Colon, Kidney, Brain, Liver | Human | Cytoplasmic | 1:25-1:100 |
c-Met/HGFR | RMab | EP1454Y | IgG | Breast, Tonsil, Cervix, Papillary Thyroid Carcinoma, Colon Carcinoma | Human | Cytoplasmic, Membranous | 1:10-1:50 |
c-Myc | MMab | 9 E10 | IgG1 | Burkitt Lymphoma, Lung Cancer, Prostate Cancer | Human | Nuclear, Cytoplasmic | 1:25-1:100 |
c-Myc | RMab | EP121 | IgG | Human, Predicted: Mouse, Rat | Nuclear, Cytoplasmic | 1:10-1:50 | |
Collagen Type IV | MMab | CIV22 | IgG1/K | Muscle, Lung | Human, Rat,Canine, Horse | Cytoplasmic | 1:50-1:200 |
COX-2 | RMab | RBT-COX2 | IgG | Colon, Testis, Kidney, Placenta, Liver, Fallopian Tube, Pancreas, Tonsil, Thymus, Breast, Adenocarcinoma of Colon, Bladder TCC | Human, Dog, Cat, Mouse, Rat | Cytoplasmic | 1:25-1:100 |
COX-2 | RMab | EP293 | IgG | Colon, Stomach, Pancreas, Breast, Lung, Adenocarcinoma of Colon | Human, Predicted Mouse | Cytoplasmic | 1:50-1:200 |
CTLA-4/CD152 | MMab | BSB-88 | IgG2a/K | Tonsil, Lymph Node, Colon, Thymus | Human, Mouse, Rat, Predicted:Canine, Equine | Membranous | 1:25-1:100 |
CTLA-4/CD152 | RMab | RBT-CTLA-4 | IgG | Tonsil, Lymph Node, Colon, Thymus | Human | Membranous | 1:125-1:100 |
Cyclin B1 | RMab | RBT-B1 | IgG | Testis, Breast, Colon,Cervix, HSIL Cervix, Lymphoblastic Lymphoma | Human | Nuclear | 1:50-1:200 |
Cyclin D1 | RMab | EP12 | IgG | Tonsil, Placenta, Brain, Pituitary, Adrenal, Cervix, Breast, Mantle Cell Lymphoma, Breast Carcinoma | Human, Predicted: Mouse, Rat | Nuclear | 1:25-1:100 |
Cyclin D1 | RMab | RBT-14 | IgG | Tonsil, Placenta, Brain, Pituitary, Adrenal, Cervix, Breast, Mantle Cell Lymphoma, Breast Carcinoma | Human, Mouse, Rat | Nuclear | 1:25-1:100 |
Cyclin E1 | RMab | EP126 | IgG | Placenta, Bladder, Colon, Breast Cancer, Ovarian Carcinoma | Human | Nuclear | 1:50-1:200 |
Cytokeratin 10 | RMab | EP97 | IgG | Squamous Cell Carcinoma | Human, Predicted: Mouse, Rat | Cytoplasmic | 1:25-1:100 |
Cytokeratin 13 | RMab | EP69 | IgG | Uterine Cervix, Urothelium | Human, Predicted: Mouse | Cytoplasmic | 1:25-1:100 |
Cytokeratin 14 | RMab | EP61 | IgG | Squamous Mucosa, Prostate, Breast, Tonsil, Salivary Gland, Skin, Cervix Carcinoma, Squamous Carcinoma | Human | Cytoplasmic | 1:50-1:200 |
Cytokeratin 14 | MMab | LL002 | IgG3 | Squamous Mucosa, Prostate, Breast, Tonsil, Salivary Gland, Skin, Cervix Carcinoma, Squamous Carcinoma | Human, Rats | Cytoplasmic | 1:50-1:200 |
Cytokeratin 15 | RMab | EP14 | IgG | Skin, Cervical Carcinoma | Human, Predicted: Mouse | Cytoplasmic | 1:25-1:100 |
Cytokeratin 16 | RMab | EP27 | IgG | Skin, Prostate, Breast, Servix, Salivary Gland,SCC | Human | Cytoplasmic | 1:50-1:200 |
Cytokeratin 17 | MMab | BSB-33 | IgG2a/K | Skin, Testis, Breast, Cervix, Cervical Carcinoma, Bladder TCC | Human, Rat, Goat and Pig | Cytoplasmic | 1:25-1:100 |
Cytokeratin 17 | MMab | EP98 | IgG | Skin, Testis, Breast, Cervix, Colon, Salivary Gland, Cervical Carcinoma, Bladder TCC,Transitional Cell Carcinoma | Human, Rat, Mouse | Cytoplasmic | 1:25-1:100 |
Cytokeratin 18 | RMab | EP30 | IgG | Liver, Kidney, Breast, GI, Prostate, Fallopian Tube | Human | Cytoplasmic | 1:25-1:100 |
Cytokeratin 19 | MMab | BSB-34 | IgG1/K | Colon, Thyroid Carcinoma | Human | Cytoplasmic | 1:100-1:500 |
Cytokeratin 19 | RMab | EP72 | IgG | Colon, Bladder, Thyroid Carcinoma, Colon Carcinoma | Human, Predicted: Mouse | Cytoplasmic | 1:50-1:200 |
Cytokeratin 20 | MMab | Ks20.8 | IgG2a/K | Colon Mucosa, Bladder, Colon Carcinoma | Human, Dog, Cat, Mouse | Cytoplasmic | 1:100-1:500 |
Cytokeratin 20 | RMab | EP23 | IgG | Colon Mucosa, Bladder, Colon Carcinoma | Human, Predicted: Rat, Goat, Pig, Marmoset | Cytoplasmic | 1:50-1:200 |
Cytokeratin 35BH11 | MMab | 35BetaH11 | IgM | Prostate, Colon | Human | Cytoplasmic | 1:50-1:200 |
Cytokeratin 4 | RMab | EP4 | IgG | Cornea, Anus, Larynx, Pharynx, Tongue, Prostate, Tonsil, Cervix, Squamous Epithelium of Esophagus, Cervical Squamous Carcinoma | Human | Cytoplasmic | 1:25-1:100 |
Cytokeratin 5 | RMab | EP24 | IgG | Prostate, Breast, Placenta, Skin, Mesothelioma | Human, Predicted: Mouse | Cytoplasmic | 1:25-1:100 |
Cytokeratin 5 & 14 | RMab | EP24 & EP61 | IgG | Breast, Prostate, Skin, Prostate Carcinoma | Human | Cytoplasmic | 1:25-1:100 |
Cytokeratin 5 & 6 | RMab | EP24 & EP67 | IgG | Prostate, Mesothelioma | Human | Cytoplasmic | 1:25-1:100 |
Cytokeratin 5 & 6 | MMab | D5 & 16B4 | IgG1 | Prostate, Mesothelioma | Human | Cytoplasmic | 1:25-1:100 |
Cytokeratin 5 & 6 & ERG | RMab | EP24, EP67 & EP111 | IgG | Breast, Prostate Carcinoma | Human | Cytoplasmic, Nuclear | 1:10-1:50 |
Cytokeratin 5 & ERG | RMab | EP24 & EP111 | IgG | Breast, Prostate Carcinoma | Human | Cytoplasmic, Nuclear | 1:25-1:100 |
Cytokeratin 6 | RMab | EP67 | IgG | Oral Mucosa, Esophagus, Skin, Glandular Epithelia | Human | Cytoplasmic | 1:25-1:100 |
Cytokeratin 7 | RMab | EP16 | IgG | Salivary Gland, Placenta, Breast, Thyroid, Cervix, Lung Adenocarcinoma | Human | Cytoplasmic | 1:50-1:200 |
Cytokeratin 7 | MMab | OV-TL 12/30 | IgG1/K | Salivary Gland, Placenta, Breast, Thyroid, Cervix, Pancreas, Fallopian Tube, Transitional Cell Carcinoma, Lung Adenocarcinoma | Human, Dog, Cat | Cytoplasmic | 1:100-1:500 |
Cytokeratin 7 & CDX2 | RMab | EP16 & EP25 | IgG | Colon, Breast, Ovary, Lung Carcinoma | Human | Cytoplasmic, Nuclear | 1:25-1:100 |
Cytokeratin 8 | RMab | EP17 | IgG | Colon, Prostate, Kidney, Liver, Colon Carcinoma | Human, Predicted: Mouse | Cytoplasmic | 1:25-1:100 |
Cytokeratin 8 & 18 | MMab | B22.1 & B23.1 | IgG1 | Breast, Ovary, GI, Prostate, Pancreas, Salivary Gland | Human | Cytoplasmic | 1:250-1:1000 |
Cytokeratin 8 & 18 | RMab | EP17 & EP30 | IgG | Breast, Ovary, GI, Prostate, Pancreas, Salivary Gland | Human | Cytoplasmic | 1:25-1:100 |
Cytokeratin Cocktail AE1 & AE3 | MMab | AE1 & AE3 | IgG1 | Prostate, Colon, Skin, Stomach | Human, Dog, Cat, Mouse, Rat, Monkey, Rabbit, Chicken, Horse | Cytoplasmic | 1:100-1:500 |
Cytokeratin HMW 34BE12 | MMab | 34BetaE12 | IgG1/K | Prostate, Cervix | Human, Dog, Cat, Monkey, Rabbit, Cattle, Horse | Cytoplasmic | 1:50-1:200 |
Cytokeratin HMW AE3 | MMab | AE3 | IgG1 | Prostate, Salivary Gland, Bladder | Human | Cytoplasmic | 1:100-1:500 |
Cytokeratin LMW | MMab | CAM5.2 | IgG2a/K | Colon, Breast , Ovarian Carcinoma | Human | Cytoplasmic | 1:10-1:50 |
Cytokeratin LMW AE1 | MMab | AE1 | IgG1 | Prostate, Salivary Gland, Bladder, Breast, Kidney, Pancreas, Cervix | Human, Mouse, Rat, Monkey, Rabbit, Chicken, Cattle, Shrew, Fish | Cytoplasmic | 1:100-1:500 |
Cytokeratin OSCAR | MMab | OSCAR | IgG2a | Breast, Liver, GI, Prostate, Colon, Skin, Stomach, Pancreas, Tonsil | Human | Cytoplasmic | 1:50-1:200 |
Cytokeratin, MNF116 | MMab | MNF116 | IgG | Breast, Cervix, Skin, Colon, Colorectal, Gastirc, Breast and Prostatic Carcinomas | Human | Cytoplasmic | 1:25-1:100 |
Cytomegalovirus | MMab | 8B1.2, 1G5.2 & 2D4.2 | IgG2a | CMV Infected Tissue | Human | Nuclear | 1:25-1:100 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Desmin | MMab | D33 | IgG1/K | Skeletal Muscle, Placenta, Colon, Prostate, Skin, Fallopian Tube | Human, Dog, Cat, Mouse, Rat, Chicken, Sheep, Hamster | Cytoplasmic | 1:25-1:100 |
Desmin | RMab | EP15 | IgG | Skeletal Muscle, Placenta, Colon, Prostate, Skin, Fallopian Tube | Human, Predicted: Mouse, Rat, Guinea Pig | Cytoplasmic | 1:25-1:100 |
Desmoglein-3 | RMab | EP306 | IgG | Tonsil, Skin, Cervix, Cervical Carcinoma, Lung Squamous Cell Carcinoma | Human | Cytoplasmic, Membranous | 1:50-1:200 |
Desmoglein-3 | MMab | BSB-61 | IgG1 | Tonsil, Skin, Cervix, Cervical Carcinoma, Lung Squamous Cell Carcinoma | Human | Cytoplasmic, Membranous | 1:25-1:100 |
DOG1 | RMab | RBT-DOG1 | IgG | Salivary Gland, Breast, GIST | Human | Cytoplasmic, Membranous | 1:100-1:500 |
DOG-1 | RMab | EP332 | IgG | A synthetic peptide corresponding to residues of human DOG1 protein | Human | Cytoplasmic, Membranous | 1:25-1:100 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
E2F4 | RMab | EP252 | IgG | Tonsil, Placenta, Testis, Breast, Cervix, Colon | Human | Nuclear | 1:50-1:200 |
E-Cadherin | RMab | EP6 | IgG | Breast, Colon, Cervix, Pancreas, Lung, Ovary, Gi Tract Adenocarcinoma, Breast Carcinoma | Human | Membranous | 1:100-1:500 |
EGFR | MMab | 31G7 | IgG1 | Skin, Placenta, Testis, Tonsil, Pancreas, Squamos Cell Carcinoma | Human | Cell Membrane | 1:25-1:100 |
EGFR Phospho | RMab | EP11 | IgG | Skin, Placenta, Testis, Tonsil, Pancreas, Squamos Cell Carcinoma | Human, Predicted: Mouse | Cell Membrane | 1:25-1:100 |
EMA | MMab | E29 | IgG2a/K | Breast, Skin, Colon, Kidney, Cervix | Human | Cytoplasmic, Membranous | 1:250-1:1000 |
EpCAM/Epithelial Specific Antigen | MMab | MOC-31 | IgG1/K | Breast ,Colon, Prostate, Kidney, Thyroid, Pancreas, Salivary Gland, Adenocarcinomas | Human | Cytoplasmic | 1:50-1:200 |
EpCAM/Epithelial Specific Antigen | MMab | Ber-EP4 | IgG1/K | Colon, Cervix, Salivary Gland, Pancreas, Breast, Thyroid, Liver, Adenocarcinomas | Human | Cytoplasmic | 1:25-1:100 |
Epstein Barr Virus LMP-1 | MMab | CS1-4 | IgG1 | EBV Infected Tissue, Hodgkin’s Lymphoma | Human | Cytoplasmic | 1:25-1:100 |
ERCC1 | RMab | EP219 | IgG | Tonsil, Testis, Breast, Prostate | Human, Predicted: Mouse | Nuclear | 1:50-1:200 |
ERG | RMab | EP111 | IgG | Prostate, Colon, Kidney, Fallopian Tube, Tonsil, Myometrium, Skin, Brain, Breast | Human, Predicted: Mouse, Rat | Nuclear | 1:100-1:500 |
Estrogen Receptor | RMab | EP1 | IgG | Breast, Myometrium, Cervix, Fallopian Tube, Breast Carcinoma | Human | Nuclear | 1:50-1:200 |
Estrogen Receptor | MMab | BSB-1 | IgG1/K | Human | Nuclear | 1:50-1:200 | |
Estrogen Receptor | RMab | RBT-11 | IgG | Human | Nuclear | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Factor VIII-Related Antigen | RPab | Polyclonal | IgG | Skin, Placenta | Human, Dog, Cat | Cytoplasmatic | 1:50-1:200 |
Factor XIIIa | RMab | EP292 | IgG | Placenta, Colon, Adrenal,Testis, Dermatofibroma | Human | Cytoplasmatic | 1:50-1:200 |
Fascin | MMab | BSB-36 | IgG2a/K | Lymph Node, Tonsil, Liver, Kidney, Adrenal, Hodgkin’s Lymphoma | Human | Cytoplasmatic | 1:250-1:1000 |
Fibrinogen | RPab | Polyclonal | IgG | Breast, Testis, Kidney, Pancreas, Salivary Gland, Skin, Fallopian Tube | Human | Cytoplasmic | 1:25-1:100 |
Fli-1 | MMab | G146-222 | IgG2b | Adrenal Gland, Fallopian Tube, Placenta, Cervix, Hemangiomas, PNET, AngioSarcoma & Soft Tissue | Human | Nuclear | 1:25-1:100 |
Follicular Dendritic Cell | MMab | CNA.42 | IgM/K | Tonsil, Lymph Node, Thymus, Colon, Skin | Human | Cytoplasmic | 1:25-1:100 |
FOXA1/HNF-3A | RMab | EP277 | IgG | Prostate, Breast, Tonsil, Colon, Fallopian Tube, Breast Carcinoma, Prostate Carcinoma | Human, Predicted Mouse and Rat | Nuclear, Cytoplasmic | 1:50-1:200 |
FOXA1/HNF-3A | RPab | Polyclonal | IgG | Prostate, Breast, Tonsil, Colon, Fallopian Tube, Breast Carcinoma, Prostate Carcinoma | Human, Mouse | Cytoplasmic, Nuclear | 1:25-1:100 |
FOXO1 | RMab | EP290 | IgG | Testis, Thyroid, Tonsil, Lymph Node, Spleen, Lung, Lymphomas | Human | Nuclear | 1:25-1:100 |
FOXP1 | RMab | EP137 | IgG | Tonsil, Lymph Node, Breast | Human, Predicted: Mouse, Rat | Nuclear, Cytoplasmic | 1:25-1:100 |
FOXP3 | RMab | EP340 | IgG | Tonsil, Lymph Node, Thymus, Colon | Human | Nuclear | 1:25-1:100 |
FOXP3 | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Thymus, Colon | Human | Nuclear | 1:25-1:100 |
FSH | MMab | BSB-55 | IgG1/K | Normal Pituitary | Human | Cytoplasmic | 1:100-1:500 |
FSH | RMab | EP257 | IgG | Pituitary | Human | Cytoplasmic | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Galectin-3 | MMab | 9C4 | IgG1 | Kidney, Testis, Salivary Gland, Breast, Tonsil, Colon, Papillary & Follicular Carcinoma of Thyroid | Human | Cytoplasmic | 1:50-1:200 |
Gastrin | RPab | Polyclonal | IgG | Stomach | Human, Dog, Cat | Cytoplasmic | 1:250-1:1000 |
GATA3 | MMab | L50-823 | IgG1/K | Breast, Skin, Placenta, Colon, Breast Carcinoma | Human, Mouse | Nuclear | 1:50-1:200 |
GATA3 | RMab | EP368 | IgG | Breast, Skin, Cervix, Breast Carcinoma | Human | Nuclear | 1:50-1:200 |
GCDFP-15 | RMab | EP95 | IgG | Breast, Sweat Glands in Skin, Breast Carcinoma | Human | Cytoplasmic | 1:50-1:200 |
GCDFP-15 | MMab | 23A3 | IgG2a | Breast, Sweat Glands in Skin, Breast Carcinoma | Human, Rat | Cytoplasmic | 1:100-1:500 |
GFAP | RMab | EP13 | IgG | Brain | Human, Predicted: Rat | Cytoplasmic | 1:25-1:100 |
GFAP | MMab | G-A-5 | IgG1 | Brain | Human, Canine, Feline, Rat, Mouse, Rabbit | Cytoplasmic | 1:250-1:1000 |
GH | MMab | BSB-99 | IgG1/K | Normal Pituitary | Human | Cytoplasmic | 1:250-1:1000 |
GH | RPab | Polyclonal | IgG | Normal Pituitary | Human | Cytoplasmic | 1:250-1:1000 |
GH | RMab | EP267 | IgG | Normal Pituitary | Human | Cytoplasmic | 1:250-1:1000 |
Glucagon | MMab | BSB-111 | IgG1/K | Pancreas, Colon | Human | Cytoplasmic | 1:250-1:1000 |
Glucagon | RMab | EP74 | IgG | Pancreas, Colon | Human, Dog, Mouse, Rat, Horse | Cytoplasmic | 1:50-1:200 |
Glucagon | RPab | Polyclonal | IgG | Pancreas, Colon | Human, Dog, Mouse, Rat, Horse | Cytoplasmic | 1:50-1:200 |
GLUT1 | RMab | EP141 | IgG | Placenta, Colon, Prostate, Skin, Kidney, Brain, Tonsil, Breast, Mesothelioma, Colon Carcinoma | Human, Predicted: Mouse, Rat | Membranous | 1:50-1:200 |
Glutamine Synthetase | MMab | GS-6 | IgG2a | Liver, Tonsil, Testis, Prostate, Hepatocellular Carcinoma, Bladder TCC | Human, Mouse, Rat | Cytoplasmic | 1:50-1:200 |
Glycophorin A | MMab | GA-R2 (HIR2) | IgG2b/K | Bone Marrow, Placenta, Tonsil, Liver, Prostate, Adrenal, Spleen, Colon, Pancreas, Fallopian Tube | Human | Membranous | 1:100-1:500 |
Glypican-3 | MMab | 1G12 | IgG1 | Melanoma, Hepatoblastoma, Hepatocellular Carcinoma | Human, Dog | Cytoplasmic | 1:100-1:500 |
Granzyme B | RMab | EP230 | IgG | Liver, Testis, Cervix, Tonsil, Lymph Node, Spleen | Human | Cytoplasmic (Granular) | 1:25-1:100 |
Granzyme B | RPab | Polyclonal | IgG | Liver, Testis, Cervix, Tonsil, Lymph Node, Spleen | Human | Cytoplasmic (Granular) | 1:25-1:100 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
hCG | MMab | BSB-38 | IgG1/K | Placenta, Brain, Pituitary, Lung Adenocarcinoma, Choriocarcinoma | Human | Cytoplasmic | 1:250-1:1000 |
HE4 | RMab | EP370 | IgG | Thyroid, Salivary Gland, Beast, Ovarian Carcinoma | Human | Cytoplasmic, Nuclear | 1:50-1:200 |
Helicobacter pylori | RPab | Polyclonal | IgG | Human | Cell Wall | 1:100-1:500 | |
Helicobacter Pylori | MMab | BSB-37 | IgG1/K | H.Pylori Infected Stomach Mucosa | Human | Cell Wall | 1:25-1:100 |
Helicobacter Pylori | RMab | EP279 | IgG | H.Pylori Infected Stomach Mucosa | Human | Cell Wall | 1:50-1:200 |
Hemoglobin A | RMab | EP124 | IgG | Bone Marrow, Placenta, Spleen | Human, Predicted: Mouse, Rat | Cytoplasmic | 1:50-1:200 |
Hepatitis B Virus Core Antigen | RPab | Polyclonal | IgG | Hepatitis B Infected Liver | Human | Nuclear | 1:25-1:100 |
Hepatitis B Virus Surface Antigen | MMab | A10F1 | IgG2b/K | Human | Cytoplasmic | 1:50-1:200 | |
Hepatocyte Specific Antigen/ Hep-Par1 | MMab | OCH1E5 | IgG1/K | Liver, Liver Carcinoma | Human, Dog, Cat | Cytoplasmic | 1:100-1:500 |
HER2 neu | RMab | EP3 | IgG | Human | Membranous | 1:50-1:200 | |
HER-2 neu | RMab | RBT-HER2 | IgG | Breast Carcinoma | Human | Membranous | 1:100-1:500 |
HER-2 neu | MMab | BSB-3 (HER-24) | IgG1 | Human | Membranous | 1:100-1:500 | |
HER2 neu Phospho | RMab | EP123 | IgG | Breast Carcinoma | Human | Membranous | 1:100-1:500 |
HER-3/c-erbB-3 | RMab | RBT-HER3 | IgG | Colon, Cervix, Bladder TCC | Human | Cytoplasmic | 1:25-1:100 |
Herpes Simplex Virus I | MMab | 10A3 | IgG1 | HSV I Infected Tissues | Human | Nuclear, Cytoplasmic | 1:50-1:200 |
Herpes Simplex Virus I | RPab | Polyclonal | IgG | Human | Nuclear, Cytoplasmic | 1:25-1:100 | |
Herpes Simplex Virus I & II | MMab | 10A3 & BSB-116 | IgG1 & IgG2a | HSV I & II Infected Tissues | Human | Cytoplasmic, Nuclear | 1:50-1:200 |
Herpes Simplex Virus I & II | RPab | Polyclonal | IgG | HSV I & II Infected Tissues | Human | Nuclear, Cytoplasmic | 1:25-1:100 |
Herpes Simplex Virus II | RPab | Polyclonal | IgG | HSV II Infected Tissues | Human | Nuclear, Cytoplasmic | 1:25-1:100 |
Herpes Simplex Virus II | MMab | BSB-116 | IgG2a | HSV II Infected Tissues | Human | Cytoplasmic, Nuclear | 1:50-1:200 |
hGAL/GCET2 | RMab | EP316 | IgG | Tonsil, Lymph Node, Thymus, Fallopian Tube, Germinal Center B-cell Type Diffuse Large B-cell Lymphoma | Human | Cytoplasmic | 1:25-1:100 |
HHV-8 | MMab | 13B10 | IgG1 | Kaposi’s Sarcoma & Soft Tissue | Human | Nuclear | 1:25-1:100 |
HIF-1alpha | RMab | EP118 | IgG | Tonsil, Cervix, Liver, Testis, Kidney, Breast, Thymus, Spleen, Colon, Cervical Cancer | Human, Predicted: Mouse, Rat | Cytoplasmic, Nuclear | 1:250-1:1000 |
Histone H3 Phospho | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Thymus, Spleen | Human | Nuclear | 1:25-1:100 |
Histone H3 Phospho | RMab | EP233 | IgG | Tonsil, Lymph Node, Thymus, Spleen | Human | Nuclear | 1:100-1:500 |
HLA-DR alpha chain | RMab | EP96 | IgG | Tonsil, Spleen, Liver, Kidney, Adrenal, Colon, Lymph Node, Thymus, Lymphobalstic Lymphoma | Human | Cytoplasmic | 1:50-1:200 |
HLA-DRB1 beta chain | RMab | EP191 | IgG | Human | Cytoplasmic | 1:25-1:100 | |
hPL | RMab | EP241 | IgG | Placenta | Human | Cytoplasmic | 1:100-1:500 |
hPL | RPab | Polyclonal | IgG | Placenta | Human | Cytoplasmic | 1:100-1:500 |
HPV | MMab | BSB-66 (SB24) | IgG1/K | Human | Nuclear | 1:100-1:500 | |
HPV16 | MMab | CAMVIR-1 | IgG2a | HPV16 Infected Tissues | Human | Nuclear | 1:250-1:1000 |
HSP-27 | MMab | G3.1 | IgG1 | Tonsil, Cervix, Prostate, Breast Carcinoma, Cervical Carcinoma | Human, Rat, Dog, Mouse, Primate | Cytoplasmic | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
IDH1 | MMab | IHC132 | IgG1 | Glioma, Glioblastoma, Astrocytoma with IDH1 R132H Mutation | Human | Cytoplasmic | 1:25-100 |
IgA | MMab | BSB-39 | IgG1/K | Tonsil, Spleen, Lymph Node, Kidney, Colon | Human | Cytoplasmic | 1:250-1:1000 |
IgA | RPab | Polyclonal | IgG | Tonsil, Spleen, Lymph Node, Kidney, Colon | Human | Cytoplasmic | 1:250-1:1000 |
IgD | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Spleen | Human | Cytoplasmic | 1:100-1:500 |
IgD | RMab | EP173 | IgG | Tonsil, Lymph Node, Spleen | Human | Cytoplasmic | 1:50-1:200 |
IgE | RPab | Polyclonal | IgG | Tonsil, Thymus, Colon | Human | N/A | 1:250-1:1000 |
IgG | MMab | BSB-40 | IgG2a/K | Tonsil, Lymph Node, Kidney, Spleen | Human, Canine, Feline | Cytoplasmic | 1:250-1:1000 |
IgG | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Kidney, Spleen | Human | Cytoplasmic | 1:250-1:1000 |
IgG4 | RMab | EP138 | IgG | Tonsil, Spleen, Colon | Human | Cytoplasmic | 1:50-1:200 |
IgG4 | MMab | BSB-96 | IgG1 | Tonsil, Spleen, Colon | Human | Cytoplasmic | 1:50-1:200 |
IgM | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Spleen, Kidney, Colon | Human | Cytoplasmic | 1:50-1:200 |
IgM | MMab | BSB-41 | IgG1/K | Tonsil, Lymph Node, Spleen, Kidney, Colon | Human | Cytoplasmic | 1:100-1:500 |
IL-1a | MMab | BSB-138 | IgG2b | Kidney, Colon, Adrenal gland, Testis, Lung | Human | Cytoplasmic, Membranous | 1:50-1:200 |
IL-1b | MMab | BSB-139 | IgG2b | Colon, Pancreas, Liver, Stomach, Brain, Testis, Lung, Transitional Cell Carcinoma, Tonsil | Human | Cytoplasmic | 1:50-1:200 |
IL-6 | MMab | BSB-140 | IgG2b | Testis, Lung, Stomach, Kidney, Transitional Cell Carcinoma | Human | Cytoplasmic, Membranous | 1:50-1:200 |
IMP-3/1GF2BP3 | RMab | EP286 | IgG | Placenta, Tonsil, Ovarian Carcinoma, TCC | Human, Predicted Mouse and Rat | Cytoplasmic, Nuclear | 1:25-1:100 |
Inhibin alpha | RMab | EP378 | IgG | Testis, Seminoma, Testicular Carcinoma | Human | Cytoplasmic | 1:50-1:200 |
Inhibin alpha | MMab | R1 | IgG2a | Placenta, Testis, Corpus Luteum, Adrenal Cortex, Testicular Carcinoma | Human, Dog, Cat | Cytoplasmic | 1:25-1:100 |
INI-1 | MMab | 25 | IgG2a | Testis, Brain, Breast, Colon, Kidney, Pituitary, Adrenal, Prostate, Thyroid, Lung, Pancreas, Cervix, Salivary Gland, Astrocytoma, Lymphoblastic Lymphoma, Transitional Cell Carcinoma | Human | Nuclear | 1:25-1:100 |
iNOS | RMab | RBT-iNOS | IgG | Testis, Adrenal, Lung, Prostate, Liver, Placenta, Spleen | Human | Cytoplasmic | 1:25-1:100 |
INSM1 | MMab | BSB-123 | IgG/K | Pancreas, Colon, Tonsil, Neuroendocrine Lung Cancer, Endometrial & Colon Carcinomas | Human | Cytoplasmic | 1:50-1:200 |
Insulin | RMab | EP125 | IgG | Pancreas | Human | Cytoplasmic | 1:50-1:200 |
Insulin | MMab | BSB-42 | IgG1/K | Pancreas | Human, Canine, Feline, Rat | Cytoplasmic | 1:250-1:1000 |
Islet 1/ISL1 | RMab | EP283 | IgG | Pancreas,Testis, Thyroid, Cervix, Skin, Pancreatic Neuroendocrine Cancer | Human | Nuclear | 1:25-1:100 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Kappa | RPab | Polyclonal | IgG | Tonsil, Lymph Node | Human | Cytoplasmic | 1:250-1:1000 |
Kappa Light Chains | MMab | BSB-58 (Kap-56) | IgG1/K | Tonsil, Lymph Node | Human, Dog, Cat | Cytoplasmic | 1:250-1:1000 |
Ki-67 | RMab | EP5 | IgG | Testis, Tonsil, Bone Marrow, Placenta, Colon, Tonsil, Fallopian Tube, Astrocytoma, Breast Carcinoma, Colon Carcinoma | Human | Nuclear | 1:25-1:100 |
Ksp-Cadherin | MMab | 4H6/F9 | IgG1 | Kidney, Chromophobe Renal Cell Carcinoma | Human | Cytoplasmic, Membranous | 1:250-1:1000 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
LAG-3/CD223 | RMab | EP294 | IgG | Testis, Lymph Node, Spleen, Lymphoblastic Lymphoma, TCC | Human | Cytoplasmic, Membranous | 1:10-1:50 |
Lambda | MMab | BSB-16 (Lamb14) | IgG2a | Tonsil, Lymph Node | Human, Dog, Cat | Cytoplasmic | 1:250-1:1000 |
Lambda | RPab | Polyclonal | IgG | Tonsil, Lymph Node | Human | Cytoplasmic | 1:250-1:1000 |
Langerin | MMab | 12D6 | IgG2b | Skin, Langerhans Histiocytosis | Human | Cytoplasmic | 1:50-1:200 |
Langerin/CD207 | RMab | EP349 | IgG | Skin, Prostate, Breast, Liver, Cervix, Salivary Gland, Langerhans Histiocytosis | Human | Cytoplasmic | 1:50-1:200 |
LEF-1 | RMab | EP310 | IgG | Breast, Tonsil, Breast Carcinoma, Small Lymphocytic Lymphoma | Human | Nuclear | 1:50-1:200 |
LH | MMab | BSB-53 | IgG1/K | Normal Pituitary | Human | Cytoplasmic | 1:100-1:500 |
LIN28 | RMab | EP150 | IgG | Testis, Seminoma, Dysgerminoma, Yolk Sac Tumor, Embryonal Carcinoma | Human | Cytoplasmic | 1:25-1:100 |
LM02 | RMab | RBT-LM02 | IgG | Tonsil, Spleen, Placenta, Follicular and Lymphoblastic Lymphoma | Human | Cytoplasmic | 1:50-1:200 |
Lysozyme | RMab | EP134 | IgG | Tonsil, Lymph Node, Liver, Kidney, Spleen, Salivary Gland, Cervix, Pancreas, Bone Marrow, Colon, Lung | Human, Predicted: Mouse | Cytoplasmic | 1:100-1:500 |
Lysozyme | RPab | Polyclonal | IgG | Tonsil, Lymph Node, Liver, Kidney, Spleen, Lung, Salivary Gland, Cervix, Pancreas, Bone Marrow, Colon, Lymphoblastic Lymphoma, Transitional Cell Carcinoma | Human | Cytoplasmic | 1:100-1:500 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Macrophage HAM-56 | MMab | HAM-56 | IgM/K | Tonsil, Lymph Node, Thymus, Spleen, Placenbta, Colon | Human, Monkey | Cytoplasmic | 1:250-1:1000 |
Mammaglobin | RMab | EP249 | IgG | Breast, Skin, Fallopian Tube, Breast Carcinoma | Human, Mouse, Monkey, Predicted: Rat | Cytoplasmic | 1:25-1:100 |
Mart-1/Melan A | MMab | M2-7C10 | IgG2b/K | Normal Skin, Melanoma | Human | Cytoplasmic | 1:250-1:1000 |
Mart-1/Melan-A | MMab | A103 | IgG1 | Normal Skin, Melanoma | Human | Cytoplasmic | 1:250-1:1000 |
Maspin | MMab | BSB-92 | IgG2a | Prostate, Breast,Tonsil | Human | Nuclear, Cytoplasmic | 1:25-1:100 |
MCM2 | RMab | RBT-MCM2 | IgG | HSIL, Cervical, Breast Cancer | Human | Nuclear | 1:100-1:500 |
MCM3 | RMab | EP202 | IgG | Colon Carcinoma | Human, Predicted: Mouse, Rat | Nuclear | 1:25-1:100 |
MCM5 | RMab | RBT-MCM5 | IgG | Tonsil, Testis, Breast, Colon, Spleen, Cervical Carcinoma, Colon Carcinoma, Transitional Cell Carcinoma, Lymphoblastic Lymphoma | Human | Nuclear | 1:100-1:300 |
MDM2 | MMab | BSB-64 | IgG1 | Testis, Tonsil, Cervix, Placenta, LipoSarcoma & Soft Tissue, Testicular Cancer | Human | Nuclear | 1:25-1:100 |
MDR-1 | MMab | JSB-1 | IgG1 | Skeletal Muscle, Kidney, Adrenal, Liver | Human | Cytoplasmic | 1:25-1:100 |
MDR-1 | RMab | EP271 | IgG | Skeletal Muscle, Kidney, Adrenal, Liver | Human, Mammalia | Cytoplasmic | 1:50-1:200 |
Melanoma Cocktail: HMB-45, MART-1 & Tyrosinase | MMab | HMB-45, A103 & BSB-6 | IgG1/K, IgG1 & IgG2a | Skin, Melanoma | Human, Dog | Cytoplasmic | 1:100-1:500 |
Melanoma KBA.62 | MMab | KBA.62 | IgG1 | Melanoma | Human | Membranous | 1:50-1:200 |
Melanoma PNL2 | MMab | PNL2 | IgG1 | Melanoma | Human, Dog | Cytoplasmic | 1:100-1:500 |
Melanosome HMB45 | MMab | HMB-45 | IgG1/K | Melanoma | Human | Cytoplasmic | 1:250-1:1000 |
Mesothelial Cell | MMab | HBME-1 | IgM/K | Breast, Tonsil, Lung, Salivary Gland, TCC, Mesothelioma | Human | Cytoplasmic, Membranous | 1:25-1:100 |
Mesothelin | RMab | EP140 | IgG | Synthetic peptide corresponding to residues on C-terminus of human mesothelin protein | Human, Dog, Cat | Cytoplasmic, Membranous | 1:50-1:200 |
MiTF | MMab | C5 & D5 | IgG1/K & IgG1/K | Skin, Melanoma | Human, Dog, Cat | Nuclear | 1:250-1:1000 |
MLH1 | MMab | G168-728 | IgG2a | Testis, Tonsil, Colon, Kidney, Colon Carcinoma | Human, Rat, Mouse | Nuclear | 1:10-1:50 |
MMP-9 | RMab | EP127 | IgG | Tonsil, Spleen, Liver, Pituitary, Colon, Lymphoblastic Lymphoma, Transitional Cell Carcinoma | Human, Predicted: Rat | Cytoplasmic | 1:50-1:200 |
MSH2 | RMab | RBT-MSH2 | IgG | Colon, Skin, Breast, Tonsil, Fallopian Tube, Colon Carcinoma | Human | Nuclear | 1:50-1:200 |
MSH2 | MMab | G219-1129 | IgG1 | Colon, Skin, Breast, Tonsil, Fallopian Tube, Colon Carcinoma | Human | Nuclear | 1:50-1:200 |
MSH6 | MMab | 44 | IgG1 | Colon Mucosa, Colon Carcinoma | Human, Rat, Mouse, Dog | Nuclear | 1:50-1:200 |
MSH6 | RMab | EP49 | IgG | Colon Mucosa, Colon Carcinoma | Human, Predicted: Mouse, Rat | Nuclear | 1:50-1:200 |
MUC1 | RMab | EP85 | IgG | Breast, Colon, Kidney, Fallopian Tube, Tonsil, Colon Adenocarcinoma | Human | Cytoplasmic | 1:50-1:200 |
MUC1 | MMab | BSB-44 | IgG1/K | Breast, Colon, Kidney, Fallopian Tube, Tonsil, Colon Adenocarcinoma | Human | Cytoplasmic | 1:250-1:1000 |
MUC2 | MMab | BSB-45 | IgG1/K | Small Intestine, Colon, Colon Adenocarcinoma | Human | Cytoplasmic | 1:250-1:1000 |
MUC2 | RMab | EP187 | IgG | Small Intestine, Colon, Colon Adenocarcinoma | Human | Cytoplasmic | 1:25-1:100 |
MUC4 | MMab | 8G7 | IgG1 | Colon, Prostate, Cervix, Placenta, Salivary Gland, Pancreatic Carcinoma, Cervical Squamous Carcinoma, Bladder TCC | Human | Cytoplasmic | 1:25-1:100 |
MUC4 | RMab | EP256 | IgG | Colon, Liver, Kidney, Pancreatic Carcinoma, Cervical Squamous Carcinoma, Bladder TCC | Human | Cytoplasmic | 1:25-1:100 |
MUC5AC | MMab | CLH2 | IgG1 | Stomach, Colon, Kidney | Human | Cytoplasmic | 1:25-1:100 |
MUC6 | MMab | CLH5 | IgG1 | Stomach | Human | Cytoplasmic | 1:100-1:400 |
MUM1 | RMab | EP190 | IgG | Tonsil, Spleen, Colon, Kidney, Breast, Lymph Node, Plasmacytoma, Hodgkin’s Lymphoma | Human, Canine, Feline | Cytoplasmic, Nuclear | 1:25-1:100 |
Mycobacterium tuberculosis | RPab | Polyclonal | IgG | Infected Tissue | Human | Cell Wall | 1:250-1:1000 |
Myelin Basic Protein | RPab | Polyclonal | IgG | Brain, Neuroblastoma | Human, Dog | Cytoplasmic | 1:50-1:200 |
Myelin Basic Protein | RMab | EP207 | IgG | Brain, Neuroblastoma | Human | Cytoplasmic | 1:25-1:100 |
Myeloperoxidase | RMab | EP151 | IgG | Bone Marrow | Human | Cytoplasmic | 1:100-1:500 |
Myeloperoxidase | RPab | Polyclonal | IgG | Bone Marrow | Human, Dog, Cat | Cytoplasmic | 1:100-1:500 |
MyoD1 | RMab | EP212 | IgG | Fetal Muscle, RhabdomyoSarcoma & Soft Tissue | Human | Nuclear | 1:50-1:200 |
Myogenin | RMab | EP162 | IgG | RhabdomyoSarcoma & Soft Tissue | Human | Nuclear | 1:50-1:200 |
Myogenin | MMab | F5D | IgG1/K | RhabdomyoSarcoma & Soft Tissue | Human, Canine, Rat, Mouse | Nuclear | 1:50-1:200 |
Myoglobin | RPab | Polyclonal | IgG | Skeletal Muscle Tissue | Human, Canine, Feline | Cytoplasmic | 1:100-1:500 |
Myoglobin | RMab | EP87 | IgG | Skeletal Muscle Tissue | Human | Cytoplasmic | 1:100-1:500 |
Myoglobin | MMab | BSB-104 | IgG1 | Skeletal Muscle Tissue | Human | Cytoplasmic, Membranous | 1:100-1:500 |
Myosin Smooth Muscle | MMab | BSB-17 (SMM-H24) | IgG1/K | Intestine, Breast, Appendix | Human, Dog, Cat | Cytoplasmic | 1:250-1:1000 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Nanog | RMab | EP225 | IgG | Testis, Cervix, Seminoma, Embryonal Carcinoma, TCC | Human | Cytoplasmic | 1:50-1:200 |
Napsin A | RMab | EP205 | IgG | Kidney, Lung, Renal Cell Carcinoma, Lung Carcinoma | Human | Cytoplasmic | 1:10-1:50 |
Napsin A | MMab | BSB-112 | IgG1/K | Kidney, Lung, Renal Cell Carcinoma, Lung Carcinoma | Human | Cytoplasmic | 1:100-1:500 |
Nestin | RMab | EP287 | IgG | Kidney, Breast, Adrenal, Myometrium, Liver Carcinoma | Human | Cytoplasmic | 1:50-1:200 |
NeuN | MMab | A60 | IgG1 | Brain | Human, Avian, Chicken, Ferret, Mouse, Pig, Rat, Salamander | Nuclear | 1:25-1:100 |
Neurofilament | MMab | 2F11 | IgG1/K | Brain | Human, Canine, Rat, Mouse, Horse | Cytoplasmic | 1:250-1:1000 |
Neurofilament | RMab | EP79 | IgG | Brain | Human | Cytoplasmic | 1:100-1:500 |
Neutrophil Elastase | RMab | EP223 | IgG | Human | Cytoplasmic | 1:50-1:200 | |
NGFR | MMab | BSB-18 | IgG1 | Brain, Breast, Prostate, Neuroblastoma, CNS Tumor | Human | Cytoplasmic | 1:250-1:1000 |
NKX2.2 | RMab | EP336 | IgG | Pancreas, Brain, Pituitary, Colon, Ewing’s Sarcoma & Soft Tissue | Human, Predicted Mouse and Rat | Nuclear | 1:50-1:200 |
NKX3.1 | RMab | EP356 | IgG | Prostate, Prostate Carcinoma | Human | Nuclear | 1:50-1:200 |
NPM1/B23 | MMab | BSB-124 | IgG1/K | Breast, Cervix, Testis, Pancreas, RCC, TCC | Human | Cytoplasmic | 1:50-1:200 |
NRAS | RMab | RBT-NRAS | IgG | Small Intestine, Melanoma, ASTMA2, Lung Carcinoma | Human | Membranous | 1:25-1:50 |
NSE | MMab | BSB-94 | IgG1/K | Pancreas, Brain, Pituitary, Adrenal, Thyroid | Human | Cytoplasmic | 1:250-1:1000 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Oct-2 | RMab | EP115 | IgG | Tonsil, Lymph Node | Human | Nuclear | 1:100-1:500 |
Oct-4 | RMab | EP143 | IgG | Seminoma, Dysgerminoma, Testis Carcinoma | Human | Nuclear | 1:50-1:200 |
OLIG2 | RMab | EP112 | IgG | Tonsil, Colon, Brain, Astrocytoma | Human, Predicted: Mouse | Nuclear | 1:50-1:200 |
Osteonectin/SPARC | MMab | BSB-93 | IgG1 | Adrnenal, Testis, Placenta, TCC, Testicular Cancer, Cervical Cancer | Human, Rat | Cytoplasmic | 1:100-1:500 |
OX-40/CD134 | MMab | BSB-90 | IgG1 | Tonsil, Lymph Node, Thymus | Human | Cytoplasmic, Membranous | 1:25-1:100 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
p120 Catenin | RMab | EP66 | IgG | Breast, Testis, Kidney, Prostate, Pancreas, Tonsil, Salivary Gland, Skin, Cervix, Colon, Malignant Melanoma, Transitional Cell Carcinoma, Breast Lobular Carcinoma | Human, Predicted: Mouse, Rat, Rabbit | Cytoplasmic, Membranous | 1:100-1:500 |
p14 ARF | RMab | RBT-p14 | IgG | Cervical, Anal and Ovarian Carcinomas | Human | Cytoplasmic | 1:25-1:100 |
p16 | MMab | 16P04, JC2 | IgG1 | Testis, NSCLC, TCC | Human | Nuclear, Cytoplasmic | 1:25-1:100 |
p16 | RMab | RBT-p16 | IgG | Testis, NSCLC, TCC | Human | Cytoplasmic, Nuclear | RTU |
p21 | MMab | DCS-60.2 | IgG2a | Tonsil, Colon, Fallopian Tube, Breast Cancer, Colon Carcinoma | Human | Cytoplasmic, Nuclear | 1:50-1:200 |
p27 | MMab | SX53G8 | IgG1/K | Testis, Breast, Adrenal, Prostate, Tonsil, Lung, Colon, Non-Small Cell Lung Carcinoma, Colon Adenocarcinoma | Human | Nuclear | 1:25-1:100 |
p40 | RMab | ZR8 | IgG | Prostate, Breast, Skin | Human | Nuclear | 1:50-1:200 |
p53 | MMab | DO7 | IgG2b/K | Lung , Breast, Ovarian Prostate, or Colon Carcinomas | Human, Cat, Cattle, Horse, Sheep, Bovine, Monkey | Nuclear | 1:250-1:1000 |
p57 | MMab | Kp10 | IgG2b/K | Placenta, Colon Carcinoma | Human | Nuclear | 1:250-1:1000 |
p63 | MMab | 4A4 | IgG2a/K | Prostate, Breast, Skin, Salivary Gland | Human | Nuclear | 1:50-1:200 |
p63 | RMab | EP174 | IgG2a/K | Prostate, Breast, Skin, Salivary Gland | Human | Nuclear | 1:50-1:200 |
pan TRK | RMab | TRK | IgG | Brain, Lung Neuroendocrine | Human | Cytoplasmic, Nuclear | 1:10-1:25 |
Parafibromin | MMab | BSB-50 | IgG1 | Parathyroid, Colon, Testis, Adrenal, Breast, Cervix, Kidney, Pituitary, Brain, Pancreas, Salivary Gland, Lymphoblastic Lymphoma, Bladder TCC, Transitional Cell Carcinoma | Human | Nuclear | 1:25-1:100 |
Parathyroid Hormone/PTH | MMab | BSB-24 | IgG1 | Parathyroid | Human | Cytoplasmatic, Membranous | 1:250-1:1000 |
Parvalbumin | RMab | EP300 | IgG | Brain, Kidney, Tonsil, Lymph Node, Chromophobe RCC | Human | Cytoplasmic | 1:25-1:100 |
Parvovirus | MMab | R92F6 | IgG1 | Parvovirus Infected Tissue | Human | Cytoplasmic, Nuclear | 1:100-1:500 |
PAX-2 | RMab | EP235 | IgG | Kidney, Fallopian Tube, Clear Cell Renal Carcinoma, Ovarian Serous Papillary Carcinoma | Human | Nuclear | 1:50-1:200 |
PAX-5 | RMab | RBT-PAX5 | IgG | Tonsil, Lymph Node, Spleen, Thymus, Colon, Liver, Lymphoblastic Lymphoma | Human, Mouse | Nuclear | 1:25-1:100 |
PAX-6 | RMab | EP341 | IgG | Pancreas, Pituitary, Neuroendocrine Tumors | Human, Predicted Mouse and Rat | Nuclear | 1:50-1:200 |
PAX-8 | RMab | ZR-1 | IgG | Ovary, Thyroid | Human | Nuclear | 1:25-1:100 |
PAX-8 | RMab | EP298 | IgG | Ovary, Thyroid | Human | Nuclear | 1:50-1:200 |
PD-1/CD279 | RMab | EP239 | IgG | Tonsil, Lymph Node, Thymus, Spleen | Human | Cytoplasmic, Membranous | 1:50-1:200 |
PD-1/CD279 | MMab | NAT-105 | IgG1 | Tonsil, Lymph Node, Thymus, Spleen | Human | Cytoplasmic | 1:100-1:500 |
PDGFR-B | RMab | RBT-PDGFRB | IgG | Placenta, Breast, Kidney, Cervix, Skin, Fallopian Tube, | Human, Mouse, Rat | Cytoplasmic | 1:10-1:50 |
PD-L1/CD274 | RMab | 28-8 | IgG | Tonsil, Placenta, Lymphoblastic Lymphoma | Human | Membranous | 1:10-1:25 |
PD-L1/CD274 | RMab | RBT-PDL1 | IgG | Tonsil, Placenta, Lymphoblastic Lymphoma | Human | Membranous | 1:25-1:100 |
PDX1 | RMab | EP139 | IgG | Pancreas, Colon, Liver, Pancreatic Cancer | Human | Nuclear | 1:50-1:200 |
Perforin | MMab | 5B10 | IgG1 | Spleen | Human | Cytoplasmic, Perinuclear | 1:50-1:200 |
PGP 9.5 | MMab | BSB-46 | IgG1/K | Brain, Testis, Colon, Pituitary, Nerve Tissue, Bowel Wall | Human | Cytoplasmic | 1:100-1:500 |
PHOX2B | RMab | EP312 | IgG | Adrenal, Neuroblastoma | Human | Cytoplasmic | 1:25-1:100 |
PLA2R1 | MMab | BSB-129 | IgG1 | Brain, Testis, Kidney, Salivary Gland, Gastic GIST | Human | Cytoplasmic, Membranous | 1:50-1:200 |
PLAP | RMab | EP194 | IgG | Placenta | Human | Cytoplasmic | 1:100-1:500 |
PLAP | MMab | BSB-47 | IgG2b/K | Placenta | Human, Rat, Mouse | Cytoplasmic | 1:250-1:1000 |
PMS2 | MMab | BSB-130 | IgG1 | Breast, Skin, Cervix, Salivary Gland, Tonsil, Ch CA, SCC | Human | Nuclear | 1:10-1:25 |
PMS2 | RMab | EP51 | IgG | Synthetic peptide corresponding to residues in human PMS2 protein | Human | Nuclear | 1:25-1:100 |
Pneumocystis jirovecii | MMab | 3F6 | IgM/K | Pneumoscystis jirovecii Infected tissue | Human | Membranous | 1:10-1:50 |
Podoplanin/D2-40 | MMab | D2-40 | IgG1 | Placenta, Breast, Lung, Cervix, Tonsil, Lymph Node, Lymphangioma | Human, Rat, Mouse | Cytoplasmic | 1:100-1:500 |
PRAME | RMab | RBT-PRAME | IgG | Tonsil, Seminoma | Human | Cytoplasmic, Nuclear | 1:50-1:200 |
Prealbumin/Transthyretin | MMab | BSB-125 | IgG | Liver, Pancreas, Kidney, Leydig Cells, Hepatocellular Carcinoma, Seminoma | Human | Cytoplasmic | 1:50-1:200 |
Progesterone Receptor | RMab | EP2 | IgG | Breast, Myometrium, Cervix, Breast Carcinoma | Human | Nuclear | 1:50-1:200 |
Progesterone Receptor | RMab | RBT-22 | IgG | Breast, Myometrium, Cervix, Breast Carcinoma | Human | Nuclear | 1:50-1:200 |
Progesterone Receptor | MMab | BSB-2 | IgG1 | Breast, Myometrium, Cervix, Breast Carcinoma | Human | Nuclear | 1:100-1:500 |
Prolactin | RMab | EP193 | IgG | Normal Pituitary | Human | Cytoplasmic | 1:100-1:500 |
Prolactin | MMab | PRL02 | IgG1/K | Normal Pituitary | Human | Cytoplasmic | 1:100-1:500 |
Prostein/P501S | RMab | EP381 | IgG | Prostate, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:50-1:200 |
PSA | MMab | BSB-7 | IgG1/K | Prostate, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:250-1:1000 |
PSA | RMab | RBT-PSA | IgG | Prostate, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:250-1:1000 |
PSAP | MMab | PASE/4LJ | IgG1 | Prostate, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:250-1:1000 |
PSAP | RMab | EP53 | IgG | Prostate, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:50-1:200 |
PSMA | RMab | EP192 | IgG | Prostate, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:50-1:200 |
PSP94/MSMB | RMab | EP203 | IgG | Prostate, Prostatic Adenocarcinoma | Human | Cytoplasmic | 1:25-1:100 |
PTEN | RMab | RBT-PTEN | IgG | Breast, Prostate, Breast & Prostatic Adenocarcinoma | Human | Cytoplasmic, Nuclear | 1:25-1:100 |
PTEN | MMab | 6H2.1 | IgG | Breast, Prostate, Breast & Prostatic Adenocarcinoma | Human, Mouse, Rat | Cytoplasmic, Nuclear | 1:25-1:100 |
PU.1 | RMab | EP18 | IgG | Tonsil, Lymp Node | Human | Nuclear | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Renal Cell Carcinoma | MMab | PN-15 | IgG1/K | Kidney, Breast, Thyroid, Renal Cell Carcinoma | Human, Rat | Cytoplasmic, Membranous | 1:50-1:200 |
Retinoblastoma/ Rb | MMab | 1F8 | IgG1/K | Colon, Breast, Skin, Fallopian Tube, Tonsil, Colon Carcinoma | Human | Nuclear | 1:25-1:100 |
ROS-1 | RMab | EP282 | IgG | Placenta, Lung, SiHa Cells, NSCL ROS1 + | Human | Cytoplasmic | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
S-100 | MMab | 4C4.9 | IgG2a | Melanoma | Human, Dog, Cat, Mouse, Rat, Cattle | Cytoplasmic, Nuclear | 1:100-1:500 |
S100A1 | RMab | EP184 | IgG | Brain, Breast, Thyroid, Tonsil, Pancreas, Salivary Gland, Renal Onocytomas, Clear Cell Carcinoma | Human, Predicted: Mouse, Rat | Cytoplasmic, Nuclear | 1:25-1:100 |
S100A6 | RMab | EP313 | IgG | Testis, Kidney, Breast, Tonsil, Colon, Carcinomas | Human | Nuclear, Cytoplasmic | 1:50-1:200 |
S100A8/MRP8 | RMab | EP90 | IgG | Tonsil, Breast, Liver, Fallopian Tube, Lymphoblastic Lymphoma | Human, Predicted: Mouse | Cytoplasmic, Nuclear | 1:10-1:50 |
S100A9 | RMab | EP185 | IgG | Tonsil, Liver, Lung, Breast, Cervix, Bone Marrow, Bladder TCC, Thyroid Carcinomas | Human | Cytoplasmic, Nuclear | 1:10-1:50 |
S100Beta | RMab | EP32 | IgG | Melanoma | Human, Predicted: Mouse, Rat, Goat, Zebrafish, Macaque Monkey | Cytoplasmic, Nuclear | 1:100-1:500 |
S100P | RMab | EP186 | IgG | Colon, Prostate, Pancreatic and Lung Carcinomas | Human | Cytoplasmic, Nuclear | 1:25-1:100 |
SALL4 | RMab | EP299 | IgG | Testis, Seminoma, Yolk Sac Tumor | Human | Nuclear | 1:10-1:50 |
SALL4 | MMab | 6 E 3 | IgG1/K | Testis, Seminoma, Yolk Sac Tumor | Human, Mouse | Nuclear | 1:50-1:200 |
SARS-CoV-2 | MMab | BSB-134 | IgG2b | SARS-CoV-2 Infected Tissues | Human | Cytoplasmic | 1:25-1:100 |
SATB2 | RMab | EP281 | IgG | Colon, Brain, Colon Carcinoma | Human | Nuclear | 1:50-1:200 |
SDHB | MMab | BSB-131 | IgG1/K | Breast, Adrenal, Prostate, Kidney, Spleen, Tonsil, Breast Carcinoma, Hepatocellular Carcinoma, Lung Adeno Carcinoma, Prostate Carcinoma, Papillary Thyroid Carcinoma | Human | Cytoplasmic, Membranous | 1:50-1:200 |
SMAD4/DPC4 | MMab | BSB-63 | IgG1 | Pancreas, Thyroid, Placenta, Cervix, TCC & Lympoblastic Lymphoma | Human | Cytoplasmic, Nuclear | 1:50-1:200 |
SMAD4/DPC4 | RMab | RBT-SMAD4 | IgG | Pancreas, Testis, Breast, Bone Marrow, Colon | Human | Nuclear, Cytoplasmic | 1:50-1:200 |
Smoothelin | MMab | R4A | IgG1 | Leiomyoma, Bladder, Prostate, Myometrium, Fallopian Tube, Colon, Transitional Cell Carcinoma | Human | Cytoplasmic | 1:25-1:100 |
Somatostatin | RPab | Polyclonal | IgG | Pancreas | Human, Dog, Horse, Lizard | Cytoplasmic | 1:100-1:500 |
Somatostatin | MMab | BSB-113 | IgG2a/K | Pancreas, Colon, Adrenal, Brain | Human | Cytoplasmic | 1:250-1:1000 |
Somatostatin | RMab | EP130 | IgG | Pancreas, Brain, Pituitary | Human | Cytoplasmic | 1:250-1:1000 |
SOX10 | RMab | EP268 | IgG | Skin, Salivary Gland, Breast, Melanoma, Schwannoma | Human, Predicted: Mouse, Rat | Nuclear | 1:50-1:200 |
SOX-10 | MMab | BSB-62 | IgG2b/K | Skin, Salivary Gland, Breast, Melanoma, Schwannoma | Human | Nuclear | 1:25-1:100 |
SOX-11 | MMab | CL0142 | IgG2a | Mantle Cell Lymphoma | Human | Nuclear | 1:25-1:100 |
SOX-2 | RMab | EP103 | IgG | Brain, Oligodendroglioma, Squamous Cell Carcinoma | Human, Predicted: Mouse | Nuclear | 1:50-1:200 |
SOX-9 | RMab | EP317 | IgG | Colon, Prostate, Skin, Breast, Tonsil, Lymph Node, Colon Carcinoma | Human, Predicted Mouse and Rat | Nuclear | 1:50-1:200 |
Spectrin | RMab | EP251 | IgG | Bone Marrow, Spleen | Human | Membranous | 1:50-1:200 |
Spectrin | MMab | RBC2/3D5 | IgG2b/K | Bone Marrow, Spleen | Human | Membranous | 1:25-1:100 |
STAR | RMab | EP226 | IgG | Leydig cells of Testis, Adrenal & Leydig Cell Tumors | Human | Cytoplasmic | 1:50-1:200 |
STAT6 | RMab | EP325 | IgG | Solitary Fibrous Tumor | Human | Nuclear | 1:50-1:200 |
Stathmin | RMab | EP247 | IgG | Testis, Tonsil, HSIL Cervical Carcinoma, Lymphoblastic Lymphoma, Bladder TCC | Human, Predicted: Mouse, Rat | Cytoplasmic, Membranous | 1:50-1:200 |
Survivin | RMab | EP119 | IgG | Colon, Placenta, Testis, Tonsil, Bone Marrow, Colon Carcinoma, Lymphoblastic Lymphoma, Bladder TCC | Human | Nuclear | 1:50-1:200 |
SV40 | MMab | Pab101 | IgG2a | SV40 Infected Tissue | Human | Nuclear | 1:25-1:100 |
Synaptophysin | RMab | EP158 | IgG | Pancreas, Brain, Pituitary, Adrenal, Colon | Human, Predicted: Mouse, Rat, Donkey | Cytoplasmic | 1:100-1:500 |
Synaptophysin | RPab | Polyclonal | IgG | Pancreas, Brain, Pituitary, Adrenal, Colon | Human, Dog, Cat | Cytoplasmic | 1:250-1:1000 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
TAG-72 | MMab | BSB-21 (Tag72-22) | IgG1/K | Testis, Spleen, Cervix, Colon, Breast Carcinoma | Human | Cytoplasmic | 1:250-1:1000 |
Tau | MMab | BSB-115 | IgG1/K | Brain, Kidney, Pituitary, Pancreas, Cervix, Skin, Salivary Gland, Astrocytoma | Human, Mouse, Rat, Canine | Nuclear, Cytoplasmic | 1:100-1:500 |
T-Bet/TBX-2 | RMab | EP263 | IgG | Spleen, Tonsil, Cervix, Liver, Breast, Hairy Cell Leukemia & Histiocytic, Lymphoblastic lymphoma, Bladder TCC | Human | Nuclear | 1:25-1:100 |
TCL1 | RMab | EP105 | IgG | Tonsil, Lymph Node | Human | Nuclear, Cytoplasmic | 1:100-1:500 |
TCR Alpha | MMab | BSB-126 | IgG1/K | Thymus, Tonsil, Lymph Node, Spleen, Hodgkin’s Lymphoma & BDCM & CCRF-CEM Cell Line | Human | Cytoplasmic | 1:25-1:100 |
TCR Beta | MMab | BSB-117 | IgG1/K | Tonsil, Lymph Node | Human | Cytoplasmic | 1:25-1:100 |
TCR Delta | MMab | BSB-127 | IgG1/K | Thymus, Tonsil, Lymph Node, Spleen | Human | Cytoplasmic, Membranous | 1:10-1:50 |
TdT | RMab | RBT-TdT | IgG | Thymus, Lymphoblastic Lymophoma | Human | Nuclear | 1:50-1:200 |
TdT | RMab | EP266 | IgG | Thymus, Lymphoblastic Lymophoma | Human | Nuclear | 1:50-1:200 |
TdT | RPab | Polyclonal | IgG | Thymus, Lymphoblastic Lymophoma | Human | Nuclear | 1:100-1:500 |
TFE3 | RMab | EP285 | IgG | Testis, Adrenal, Kidney, Testicular Cancer, RCC with Xp11.2 translocation, Alveolar Soft Part Sarcoma & Soft Tissue | Human | Nuclear | 1:50-1:200 |
Thrombomodulin/ CD141 | RMab | EP175 | IgG | Placenta, Liver, Kidney, Tonsil, Cervix, Bladder, Mesothelioma, Transitional Cell Carcinoma | Human | Membranous, Cytoplasmic | 1:10-1:50 |
Thyroglobulin | RMab | EP250 | IgG | Thyroid, Thyorid Carcinoma | Human | Cytoplasmic | 1:250-1:1000 |
Thyroglobulin | MMab | BSB-49 | IgG1 | Thyroid, Thyorid Carcinoma | Human, Cat | Cytoplasmic | 1:250-1:1000 |
Thyroglobulin | MMab | 2H11 & 6E1 | IgG1/K & IgG1/K | Thyroid, Thyorid Carcinoma | Human, Dog, Cat | Cytoplasmic | 1:250-1:1000 |
Thyroid Peroxidase | RMab | EP159 | IgG | Thyroid, Thyorid Carcinoma | Human | Cytoplasmic | 1:100-1:500 |
TIA-1 | MMab | TIA-1 | IgG1 | Tonsil, Spleen, Liver, Anaplastic Large Cell Lymphoma | Human | Cytoplasmic (Granular) | 1:25-1:100 |
TLE1 | MMab | 1F5 | IgG1/K | Synovial Sarcoma & Soft Tissue | Human | Cytoplasmic, Nuclear | 1:10-1:50 |
TMPRSS2 | MMab | BSB-136 | IgG1 | Testis, Colon, Kidney, Brain, Stomach. Pancreas, Prostate | Human | Nuclear, Membranous | 1:50-1:200 |
TNFa-IP2 | MMab | BSB-141 | IgG1 | Testis, Tonsil, Lung, Kidney | Human | Cytoplasmic, Membranous | 1:50-1:200 |
Topoisomerase IIa | RMab | RBT-Topo2a | IgG | Testis, Skin, Colon, Fallopian Tube, Tonsil, Lymph Node, Spleen, HSIL Cervical Cancer, Breast Cancer, Bladder TCC | Human | Nuclear | 1:50-1:200 |
Toxoplasma gondii | RPab | Polyclonal | IgG | Toxoplasma gondii Infected Tissue | Human | Nuclear | 1:50-1:200 |
TRAcP | MMab | 9C5 | IgG2b | Tonsil, Spleen, Lymph Node, Hairy Cell Leukemia | Human | Cytoplasmic | 1:100-1:500 |
Treponema pallidum | RPab | Polyclonal | IgG | Infected Tissue | Eubacteria | Cell Wall | 1:250-1:1000 |
Tryptase | RMab | EP259 | IgG | Liver, Kidney, Tonsil, Uterus, Cervix, Skin, Colon | Human | Cytoplasmic | 1:50-1:200 |
Tryptase | MMab | G3 | IgG1 | Liver, Kidney, Tonsil, Uterus, Cervix, Skin, Colon | Human | CytoPlasmic | 1:100-1:500 |
TSH | MMab | BSB-56 | IgG1/K | Pituitary | Human | Cytoplasmic | 1:250-1:1000 |
TSH | RMab | EP254 | IgG | Pituitary | Human, Predicted: Rabbit | Cytoplasmic | 1:250-1:1000 |
TTF-1 | MMab | 8G7G3/1 | IgG1 | Lung, Thyroid, Adenocarcinoma of Lung | Human, Dog | Nuclear | 1:250-1:1000 |
Tyrosinase | MMab | BSB-6 (Ty/G5) | IgG2a | Skin, Malignant Melanoma | Human | Cytoplasmic | 1:50-1:200 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Uroplakin III | RMab | EP321 | IgG | A synthetic peptide corresponding to residues of human Uroplakin III protein | Human | Nuclear | 1:50-1:200 |
Uroplakin III | RPab | Polyclonal | IgG | Bladder, Bladder Carcinoma | Human | Cytoplasmic, Membranous | 1:25-1:100 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Varicella Zoster Virus | MMab | SG1-1 | SG1, SG1-S | Varicella Zoster Virus Infected Tissue | Human | Cytoplasmic, Membranous | 1:25-1:100 |
VEGF | RMab | RBT-VEGF | IgG | Placenta, Angioma, AngioSarcoma & Soft Tissue | Human | Cytoplasmic, Cell Surface | 1:10-1:50 |
Villin | RMab | EP163 | IgG | Kidney, Colon, Small Bowel Mucosa, Colonic Mucosa | Human | Cytoplasmic, Membranous | 1:100-1:500 |
Villin | MMab | CWWB1 | IgG1 | Kidney, Colon, Small Bowel Mucosa, Colonic Mucosa | Human | Cytoplasmic, Membranous | 1:25-1:100 |
Vimentin | RMab | EP21 | IgG | Tonsil, Lymph Node, Colon | Human, Predicted: Mouse, Rat, Rhesus Monkey | Cytoplasmic | 1:50-1:200 |
Vimentin | MMab | V9 | IgG1/K | Tonsil, Lymph Node, Colon | Human, Dog, Cat, Rat, Rabbit, Cattle, Horse, Guinea Pig | Cytoplasmic | 1:250-1:1000 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
WT1 | MMab | 6F-H2 | IgG1/K | Kidney, Testis, Malignant Mesothelioma | Human | Nuclear | 1:100-1:500 |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Antibody Name | Type | Clone | Isotype | Tissue Control | Species Reactivity | Localization | Dilution Range |
Zap-70 | MMab | 2F3.2 | IgG2a | Tonsil, Lymph Node, Thymus, Chronic Lymphocytic Leukemia | Human | Cytoplasmic | 1:250-1:1000 |